Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Form 8 (OPD)

10 Apr 2017 10:11

RNS Number : 0515C
Element Materials Tech Group Ltd
10 April 2017
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Element Materials Technology Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Exova Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

7 April 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

Β 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

Β 

TOTAL:

Nil

0

Nil

0

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

None.

Details, including nature of the rights concerned and relevant percentages:

None.

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

10 April 2017

Contact name:

Jo Wetz

Telephone number:

+44 (0)2035 401 823

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEEURRKRBWASARR
Date   Source Headline
24th Apr 20175:25 pmRNSForm 8.5 (EPT/RI)
24th Apr 20175:23 pmRNSForm 8.5 (EPT/RI) - Exova Group Plc - Amendment
24th Apr 20174:46 pmRNSForm 8.3 - Exova Group Plc
24th Apr 20174:44 pmRNSForm 8.3 - Exova Group Plc
24th Apr 20173:29 pmRNSForm 8.3 - Exova Group Plc
24th Apr 20172:29 pmRNSDirector Declaration
24th Apr 20171:49 pmRNSForm 8.3 - Exova Group Plc
24th Apr 201711:38 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
24th Apr 201710:20 amRNSForm 8.5 (EPT/RI)
21st Apr 20173:49 pmRNSForm 8.5 (EPT/RI) - Replacement
21st Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
21st Apr 201711:56 amRNSForm 8.5 (EPT/RI)
21st Apr 201711:34 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
21st Apr 201711:15 amRNSForm 8.5 (EPT/RI)
20th Apr 20174:50 pmRNSTR-1: Notification of Major Interest in Shares
20th Apr 20174:22 pmRNSForm 8.3 - Exova Group plc
20th Apr 20173:30 pmRNSForm 8.3 - [Exova Group]
20th Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
20th Apr 20173:02 pmBUSForm 8.3 - Exova Group plc
20th Apr 20172:11 pmRNSForm 8.3 - Exova Group plc
20th Apr 201711:50 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
20th Apr 201711:34 amRNSForm 8.3 - EXOVA GROUPL PLC
20th Apr 201711:18 amRNSForm 8.5 (EPT/RI)
20th Apr 201711:11 amRNSForm 8.3 - EXOVA GROUP PLC
20th Apr 201710:53 amRNSForm 8.3 - EXOVA GROUP PLC
20th Apr 201710:25 amRNSForm 8.5 (EPT/RI)
20th Apr 20177:00 amBUSForm 8.3 - Exova Group Plc
19th Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
19th Apr 20172:12 pmRNSForm 8.3 - Exova Group PLC
19th Apr 201710:05 amRNSForm 8.5 (EPT/RI)
19th Apr 20177:00 amRNSRECOMMENDED CASH ACQUISITION of EXOVA GROUP PLC
19th Apr 20177:00 amBUSForm 8.3 - Exova Group Plc
18th Apr 20173:03 pmRNSForm 8.3 - Exova Group PLC
18th Apr 201710:33 amRNSForm 8.5 (EPT/RI)
13th Apr 20173:03 pmRNSForm 8.3 - Exova Group Plc
13th Apr 201710:02 amRNSForm 8.5 (EPT/RI)
12th Apr 20172:58 pmRNSForm 8.3 - Exova Group Plc
12th Apr 201712:03 pmRNSForm 8.3 - Exova Group plc (Amended)
12th Apr 201711:00 amRNSAnnual Report & Accounts 2016 & Notice of 2017 AGM
12th Apr 201710:31 amRNSForm 8.5 (EPT/RI)
12th Apr 201710:19 amRNSForm 8.5 (EPT/RI)
11th Apr 20174:25 pmRNSForm 8.3 - Exova Group PLC
11th Apr 20173:30 pmRNSAcquisition
11th Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
11th Apr 201711:12 amRNSForm 8.5 (EPT/RI) Exova Group Plc
10th Apr 20173:20 pmRNSForm 8.3 - Exova Group Plc
10th Apr 20172:31 pmRNSForm 8.3 - Exova Group plc
10th Apr 201712:14 pmRNSForm 8.3 - Exova Group Plc
10th Apr 201710:32 amRNSForm 8.5 (EPT/RI)
10th Apr 201710:24 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.